The vasovagal syncope and pacing (Synpace) trial: Rationale and study design

Europace

Volumn 3, Issue 4, 2001, Pages 336-341

  Raviele, Antonio ^a   Giada, F ^a   Sutton, R ^b   Alboni, P ^c   Brignole, M ^d   Del Rosso, A ^c   Di Girolamo, E ^e   Luise, R ^c   Menozzi, C ^f  

^a Ospedale Umberto I   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Ospedale Civile   (Italy)

^d Ospedale Riuniti   (Italy)

^e Ospedale Clinicizzato SS Annunziata   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Dual chamber pacemaker; Vasovagal syncope

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ALGORITHM; ARTICLE; ASYSTOLE; BRADYCARDIA; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; HEAD POSITION; HEAD TILTING; HEMODYNAMICS; HUMAN; IMPLANTATION; METHODOLOGY; MULTICENTER STUDY; PACEMAKER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; RISK; SAMPLE; SYNCOPE;

DATABASES; HEMODYNAMIC PROCESSES; HUMANS; PACEMAKER, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESEARCH DESIGN; SAMPLE SIZE; SOFTWARE; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 0034775087     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2001.0192     Document Type: Article

References (23)

1. Epidemiologic features of isolated syncope: The Framingham study
2. Evaluation and outcome of emergency room patients with transient loss of consciousness
3. Usefulness of head-up tile test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
4. Impairment of physical and psychosocial function in recurrent syncope
5. Recurrent syncope as a chronic disease: Preliminary validation of disease-specific measure of functional impairment
6. Health-related quality of life in patients with neuromediated syncope
7. Risk factors for syncope recurrence after a positive tilt table test in patients with syncope
8. Recurrence of neurocardiogenic syncope without pharmacologic interventions
9. Timing of first syncope recurrence predicts syncope frequency following a positive tilt table test
10. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of ethylephrine vs placebo
11. A controlled trial of acute and long-term medial therapy in tilt-induced neurally mediated syncope
12. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt
13. Effect of etylephrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind, randomized, placebo-controlled trial
14. Midodrine: A role in the management of neurocardiogenic syncope
15. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
16. Cardiac pacing for the prevention of recurrent vasovagal syncope
17. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
18. Clinical experience with Thera DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope
19. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope
20. A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
21. Dual-chamber pacing is efficacious in treatment of neurally-mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicenter randomized study
22. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope
23. Tilt test potenziato con nitroglicerina orale nei pazienti con sincope inspiegata: 'II Protocollo Italiano'